Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Clermont-Ferrand
Clinical trial register · France

Clinical Trials in Clermont-Ferrand, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9722 matching records held by the registry are in this view. Synced 29 Oct 2026, 03:20 UTC
9722
Studies in scope
all four open statuses
6047
Recruiting now
open to new participants
1031
Lead sponsors
across recruiting studies
Top sites
Paris 64 Bordeaux 62 Montpellier 61 Lyon 60 Marseille 58
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Hospital, Clermont-Ferrand151 Hospices Civils de Lyon31 UNICANCER27 Assistance Publique - Hôpitaux de Paris25 AstraZeneca24 Clear sponsor filter
Site location
Paris64 Bordeaux62 Montpellier61 Lyon60 Marseille58
All 106 locations
Target enrolment
to

Trials with a site in Clermont-Ferrand

24 of 9722 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
AstraZeneca
Phase 3
245
Clermont-Ferrand, Lyon, Marseille, Paris, Pessac, Saint-Denis, Saint-Pierre, Toulon
2026-04-13
Recruiting
AstraZeneca
Phase 3
100
Clermont-Ferrand, La Roche-sur-Yon, Montpellier, Paris, Pierre-Bénite
2025-10-30
Recruiting
AstraZeneca
Phase 3
700
Angers, Bordeaux, Caen, Clermont-Ferrand, Le Mans, Marseille, Montpellier, Nice
2025-08-06
Recruiting
AstraZeneca
Phase 3
600
Besançon, Bordeaux, Caen, Clermont-Ferrand, Lyon, Montpellier, Nice, Paris
2025-03-27
Recruiting
AstraZeneca
Phase 3
5,000
Amiens, Bordeaux, Boulogne-Billancourt, Brest, Clermont-Ferrand, Créteil, La Roche-sur-Yon, Le Mans
2025-03-03
Recruiting
AstraZeneca
Phase 3
840
Bordeaux, Caen, Clermont-Ferrand, Dijon, Lyon, Marseille, Poitiers, Rennes
2025-03-01
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
NCT06564038Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma
DrugsSurovatamig·Acalabrutinib·Vincristine·Doxorubicin
AstraZeneca
Phase 1/2
408
Clermont-Ferrand, Montpellier, Paris, Saint-Cloud, Villejuif
2025-01-30
Recruiting
AstraZeneca
Observational
126
Clermont-Ferrand, Gleizé, Grenoble, Lyon, Metz-Tessy, Saint-Etienne, Saint-Priest-en-Jarez, Thonon-les-Bains
2024-12-30
Active, closed
AstraZeneca
Phase 3
2,554
Amiens, Annonay, Bois-Guillaume, Bordeaux, Boulogne-Billancourt, Brest, Clermont-Ferrand, La Roche-sur-Yon
2024-03-29
Active, closed
AstraZeneca
Phase 3
1,898
Angers, Bayonne, Bordeaux, Caen, Clermont-Ferrand, Créteil, Lyon, Montpellier
2023-11-21
Active, closed
AstraZeneca
Phase 3
1,902
Avignon, Bayonne, Caen, Clermont-Ferrand, Limoges, Marseille, Montpellier, Nice
2023-11-14
Active, closed
AstraZeneca
Phase 3
5,511
Angers, Bordeaux, Caen, Clermont-Ferrand, Dijon, Epagny Metz-Tessy, Lille, Lyon
2023-10-05
Recruiting
AstraZeneca
Phase 3
4,300
Angers, Argenteuil, Avignon, Bordeaux, Bourg-en-Bresse, Caen, Cholet, Clermont-Ferrand
2023-03-31
Active, closed
AstraZeneca
Observational
551
Nice, Clermont-Ferrand, Strasbourg, Finist Re, Dijon, Bordeaux, Grenoble, Saint-Denis
2023-02-27
Active, closed
AstraZeneca
Observational
254
Angers, Argenteuil, Avignon, Bayonne, Bordeaux, Clermont-Ferrand, Créteil, Dijon
2022-11-14
Active, closed
AstraZeneca
Phase 3
594
Angers, Clamart, Clermont-Ferrand, Créteil, Lyon, Montpellier, Nantes, Paris
2022-09-15
Active, closed
AstraZeneca
Phase 3
1,035
Bordeaux, Brest, Clermont-Ferrand, Créteil, Montpellier, Paris, Rouen, Saint-Herblain
2022-03-25
Active, closed
AstraZeneca
Phase 3
1,051
Avignon, Besançon, Bordeaux, Clermont-Ferrand, Créteil, Lorient, Marseille, Montpellier
2022-02-07
Active, closed
AstraZeneca
Phase 3
712
Amiens, Bayonne, Clermont-Ferrand, Lille, Lyon, Marseille, Montpellier, Nice
2021-08-05
Active, closed
AstraZeneca
Phase 3
315
Avignon, Brest, Clermont-Ferrand, Dijon, Limoges, Lorient, Lyon, Marseille
2021-06-30
Active, closed
AstraZeneca
Phase 3
370
Avignon, Bordeaux, Clermont-Ferrand, Dijon, Lyon, Marseille, Montpellier, Strasbourg
2020-10-02
Active, closed
AstraZeneca
Phase 1/2
264
Bordeaux, Caen, Clermont-Ferrand, Dijon, Marseille, Nantes, Paris, Pierre Benit Cedex
2016-03-17
Active, closed
AstraZeneca
Phase 3
1,837
Avignon, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dechy, La Roche-sur-Yon
2014-04-22
Active, closed
AstraZeneca
Phase 3
510
Brest, Caen, Clermont-Ferrand, Dijon, Lille, Marseille, Paris, Pierre-Bénite
2013-09-25
Rows per page Showing 1–24 of 24
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-france/city/clermont-ferrand

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,722 studies in total at the last sync on 29 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 24 of those studies with a site in Clermont-Ferrand that also match the filters currently applied.

How many clinical trials are recruiting in Clermont-Ferrand?

9 of the 24 studies on this page are recruiting new participants as of the 29 Oct 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 15 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Clermont-Ferrand), 24 studies
PhaseStudiesRecruitingShare
Phase 319779.2%
Observational3112.5%
Phase 1/2218.3%

Most active sponsors

Lead sponsors with the most studies (Clermont-Ferrand)
Lead sponsorStudiesRecruiting
AstraZeneca249
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.